Стекловидноклеточные карциномы шейки матки

Цель исследования – выявить особенности частоты встречаемости, клинической картины, методов диагностики и лечения стекловидноклеточных карцином (glassy cell carcinoma, GCC) шейки матки.

Материалы и методы. В публикации освещены 4 случая диагностированных GCC шейки матки в ФГБУ «Национальный медицинский исследовательский центр онкологии им. Н. Н. Петрова» Минздрава России за 5‑летний период – с 2015 по 2020 г.

Результаты. Частота встречаемости GCC шейки матки составляет 1,08 % всех случаев рака шейки матки. Все пациентки в исследовании имели местно-распространенную форму заболевания II и III стадий. Всем пациенткам проводилось индивидуализированное лечение. Во всех случаях наблюдалось прогрессирование заболевания на фоне проводимого лечения.

Выводы. Основная проблема заключается в редкой встречаемости GCC шейки матки. Выбор тактики лечения решается только мультидисциплинарно и требует дальнейших исследований.

1. Злокачественные новообразования в России в 2019 году(заболеваемость и смертность). Под ред. А.Д. Каприна, В.В. Старинского, А.О. Шахзадовой. Злокачественные новообразования в России в 2019 году(заболеваемость и смертность). М.: МНИОИ им. П.А. Герцена – филиал ФГБУ «НМИЦ радиологии» Минздрава Рос- сии, 2020. 252 с.

2. Guitarte C., Alagkiozidis I., Mize B. et al. Glassy cell carcinoma of the cervix: a systematic review and meta-analysis. Gynecol Oncol 2014;133:186–91. DOI: 10.1016/j.ygyno.2014.01.048.

3. Alfsen G.C., Thoresen S.O., Kristensen G.B. et al. Histopathologic subtyping of cervical adenocarcinoma reveals increasing incidence rates of endometrioid tumors in all age groups: a population based study with review of all nonsquamous cervical carcinomas in Norway from 1966 to 1970, 1976 to 1980, and 1986 to 1990. Cancer 2000;89(6):1291–9.

4. SEER Cancer Statistics Review. Eds.: Ries L.A.G., Harkins D., Krapcho M. et al. Bethesda: National Cancer Institute, 1975–2003.

5. Glucksmann A., Cherry C. Incidence, histology, and response to radiation of mixed carcinomas (adenoacanthomas) of the uterine cervix. Cancer 1956;9:971–9. DOI: 10.1002/1097-0142(195609/10)9:5<971::aid-cncr2820090518>3.0.co;2-t.

6. Littman P., Clement P.B., Henriksen B. et al. Glassy cell carcinoma of the cervix. Cancer 1976;37:2238–46. DOI: 10.1002/1097-0142(197605)37:5<2238::aid-cncr2820370513>3.0.co;2-d.

7. Kurman R.J., Carcangiu M.L., Herrington C.S., Young R.H. WHO Classification of Tumors of Female Reproductive Organs. Lyon: International Agency for Research on Cancer, 2014.

8. Lotocki R.J., Krepart G.V., Paraskevas M. et al. Glassy cell carcinoma of the uterine cervix: a bimodal treatment strategy. Gynecol Oncol 1992;44:254–9. DOI: 10.1016/0090-8258(92)90052-k.

9. Kim S.K., Shim H.S., Lee K.G. et al. Glassy cell carcinoma predominantly commits to a squamous lineage and is strongly associated with high-risk type human papillomavirus infection. Int J Gynecol Pathol 2009;28:389–95. DOI: 10.1097/PGP.0b013e31819343a5.

10. Kenny M.B., Unger E.R., Chenggis M.L., Costa MJ. In situ hybridization for human papillomavirus DNA in uterine adenosquamous carcinoma with glassy cell features (“glassy cell carcinoma”). Am J Clin Pathol 1992;98(2):180–7.

11. Gray H.J., Garcia R., Tamimi H.K. et al. Glassy cell carcinoma of the cervix revisited. Gynecol Oncol 2002;85:274–7. DOI: 10.1006/gyno.2001.6523.

12. Reis-Filho J.S., Fillus Neto J., Schonemann E. et al. Glassy cell carcinoma of the uterine cervix. Report of a case with cytohistologic and immunohistochemical study. Acta Cytol 2001;45: 407–10. DOI: 10.1159/000327639.

13. Deshpande A., Kotwal M., Bobhate S. Glassy cell carcinoma of the uterine cervix: a rare histology. Report of three cases with a review of the literature. Indian J Cancer 2004;41:92–5.

14. Costa M.J., Kenny M.B., Hewan-Lowe K., Judd R. Glassy cell features in adenosquamous carcinoma of the uterine cervix – histologic, ultrastructural, immunohistochemical and clinical findings. Am J Clin Pathol 1991;96:520–8.

15. Zhu H.T., Li S.X. Glassy cell carcinoma of the cervix: a clinicopathologic analysis of 5 cases Chin. J Pathol 2011;40(8):523–7.

16. Piura B., Rabinovich A., Meirovitz M., Yanai-Inbar I. Glassy cell carcinoma of the uterine cervix. J Surg Oncol 1999;72:206–10.

17. Nasu K., Takai N., Narahara H. Multimodal treatment of glassy cell carcinoma of the uterine cervix. J Obstet Gynaecol Res 2009;35(3):584–7.

18. Ferrandina G., Salutari V., Petrillo M. et al. Conservatively treated glassy cell carcinoma of the cervix. World J Surg Oncol 2008;6:92.

19. Nahhas W.A., Abt A.B., Mortel R. Stage IB glassy cell carcinoma of the cervix with ovarian metastasis. Gynecol Oncol 1977;5:87–91.

20. Reisinger S.A., Palazzo J.P., Talerman A. et al. Stage IB glassy cell carcinoma of the cervix diagnosed during pregnancy and recurring in transposed ovary. Gynecol Oncol 1991;42:86–90.

21. Hirashima Y., Kobayashi H., Nishiguchi T. et al. A case of glassy cell carcinoma of the uterine cervix effectively responding to chemotherapy with paclitaxel and carboplatin. Anticancer Drugs 2001;12:627–30. DOI: 10.1097/00001813-200108000-00010.

22. Matsuura Y., Murakami N., Nagashio E. et al. Glassy cell carcinoma of the uterine cervix: combination chemotherapy with paclitaxel and carboplatin in recurrent tumor. J Obstet Gynecol Res 2001;27:129–32.

23. Takekuma M., Hirashima Y., Takahashi N. et al. A case of glassy cell carcinoma of the uterine cervix that responded to neoadjuvant chemotherapy with paclitaxel and carboplatin. Anticancer Drugs 2006;17:715–8. DOI: 10.1097/01.cad.0000217420.14090.a9.

24. Nagai T., Okubo T., Sakaguchi R. et al. Glassy cell carcinoma of the uterine cervix responsive to neoadjuvant intraarterial chemotherapy. Int J Clin Oncol 2008;13:541–4.

25. Mikami M., Ezawa S., Sakaiya N. et al. Response of glassy cell carcinoma of the cervix to cisplatin, epirubicin, and mitomycin C. Lancet 2000;355:1159–60.

26. Inoue T., Okumura M. Prognostic significance of parametrial extension in patients with cervical carcinoma stages IB, IIA and IIB: a study of 628 cases treated by radical hysterectomy and lymphadenectomy with and without postoperative radiation. Cancer 1984;54:1714–9.DOI: 10.1002/1097-0142(19841015)54:8<1714::aidcncr2820540838>3.0.co;2-s.

27. Sevin B.U., Lu Y., Bloch D. et al. Surgically defined prognostic parameters in patients with early cervical carcinoma: a multivariate survival tree analysis. Cancer 1996;78:1438–46.

28. Zreik T.G., Chambers J.T., Chambers S.K. Parametrial involvement, regardless of nodal status: a poor prognostic factor for cervical cancer. Obstetric Gynecol 1996;87:741–6.

29. Estape R.E., Angioli R., Madrigal M. et al. Close vaginal margins as a prognostic factor after radical hysterectomy. Gynecol Oncol 1998;68:229–32. DOI: 10.1006/gyno.1998.4960.

30. Peters W.A., Liu P.Y, Barrett R.J. et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 2000;18:1606–13.

31. Koh W.J., Panwala K., Greer B. Adjuvant therapy for high-risk, early stage cervical cancer. Semin Radiat Oncol 2000;10:51–60.

32. Kuroda H., Toyozumi Y., Masuda T. et al. Glassy cell carcinoma of the cervix: cytologic features and expression of estrogen receptor, progesterone receptor and HER2/neu protein. Acta Cytol 2006;50:418–22. DOI: 10.1159/000325985.

33. Kosinska-Kaczynska K., Mazanowska N., Bomba-Opon D. et al. Glassy cell carcinoma of the cervix – a case report with review of the literature. Ginekol Pol 2011;82:936–9.

34. Dieterle S., Mesrogli M., Gunter H.H., Kuhnle H. Glassy cell carcinoma of the cervix. Geburtshilfe Frauenheilkd 1991;51:484–5.

35. Corn B.W., Micaily B., Dunton C.J. et al. Concomitant irradiation and doseescalating carboplatin for locally advanced carcinoma of the uterine cervix. An updated report. Am J Clin Oncol 1998;21:31–5.

36. Seltzer V., Sall S., Castadot M.J. et al. Glassy cell cervical carcinoma. Gynecol Oncol 1979;8:141–51.

37. Hopkins M., Morley G. Glassy cell adenocarcinoma of the uterine cervix. Am J Obstet Gynecol 2004;190:67–70. DOI: 10.1016/s0002-9378(03)00928-1.

38. Tamimi H.K., Ek M., Hesla J. et al. Glassy cell carcinoma of the cervix redefined. Obstet Gynecol 1988;71:837–41.

39. Talerman A., Alenghat E., Okagaki T. Glassy cell carcinoma of the uterine cervix. APMIS Suppl 1991;23:119–25.

40. Yoon N., Yoon G., Park C.K., Kim H.S. Stromal p16 expression is significantly increased in malignant ovarian neoplasms. Oncotarget 2016;7(40):64665–73. DOI: 10.18632/oncotarget.11660.

41. Сафронова К.В., Артемьева А.С., Сидорук А.А. и др. Меланома нижнего женского полового тракта (вульвы, влагалища и шейки матки): обзор литературы и собственные наблюдения. Опухоли женской репродуктивной системы 2019;15(3):44–53.

42. Сафронова К.В., Артемьева А.С., Нюганен А.О. и др. Саркомы нижнего женского полового тракта (вульвы, влагалища и шейки матки): обзор литературы и собственные наблюдения. Опухоли женской репродуктивной системы 2019;15(3):54–63.